![]() ![]() No Survival Benefit with Chemo for STS from Bone In a multivariable analysis, only myxofibrosarcoma histology proved to be an independent predictor of local recurrence (HR 6.424, 95% CI 1.796-22.978, P=0.004). For various reasons, 81 patients did not have perioperative radiation therapy. 1, 2010 through May 8, 2019, all of whom were candidates for perioperative radiotherapy. Saxby and colleagues reviewed data for 166 patients treated for STS from Sept. Multimodal therapy has become standard for STS, although surgery alone may be used in certain clinical circumstances - including delayed wound healing, perceived negative margins, and patient preference. "In these circumstances, the addition of radiation or a wider excision is recommended to minimize the likelihood of local recurrence." "However, durable local control may be more difficult in myxofibrosarcoma and resections with close or positive margins," the investigators stated. ![]()
0 Comments
Leave a Reply. |